Table 2. Mean radiation absorbed doses from radiolabeled DOTA-biotin in Ramos-xenografted mice pretargeted with 1F5-SA.
177Lu-DOTA-Biotin | 90Y-DOTA-Biotin | |||||
---|---|---|---|---|---|---|
Tissue | Gy/MBq | Gy/37 MBq | TNTDR a | Gy/MBq | Gy/37 MBq | TNTDR a |
Blood | 0.066 | 2.4 | 9.4 | 0.108 | 4.0 | 12.4 |
Lung | 0.043 | 1.6 | 14.5 | 0.213 | 7.9 | 6.3 |
Liver | 0.072 | 2.7 | 8.6 | 0.180 | 6.7 | 7.5 |
Spleen | 0.043 | 1.6 | 14.5 | 0.154 | 5.7 | 8.7 |
Stomach | 0.023 | 0.9 | 27.0 | 0.037 | 1.4 | 36.3 |
Kidney | 0.275 | 10.2 | 2.3 | 0.348 | 12.9 | 3.9 |
Small intestine | 0.019 | 0.7 | 32.7 | 0.039 | 1.4 | 34.4 |
Large intestine | 0.060 | 2.2 | 10.4 | 0.161 | 6.0 | 8.3 |
Muscle | 0.011 | 0.4 | 56.5 | 0.056 | 2.1 | 24.0 |
Femur | 0.015 | 0.6 | 41.5 | 0.028 | 1.0 | 48.0 |
Tail | 0.039 | 1.4 | 15.9 | 0.036 | 1.3 | 37.3 |
Carcass | 0.027 | 1.0 | 23.0 | 0.069 | 2.6 | 19.5 |
Tumor | 0.622 | 23.0 | 1.343 | 49.7 |
aTNTDR = Tumor-to-normal tissue dose ratio
n = 5 per treatment and time point (4, 24, 48, and 120 hours p.i.)